Discover
VVOS
Vivos Therapeutics, Inc.
0.50
2 x 0.36
2 x 0.61
bid
ask
+
0.04
9.64%
2 @ 04:00 PM
0.43 -0.07 (14.69%)
| Ytd | -75.45% | |
| 1y | -86.99% |
0.46
day range
0.53
0.38
52 week range
7.95
| Open | 0.47 | Prev Close | 0.45 | Low | 0.46 | High | 0.53 | Mkt Cap | 6.92M |
| Vol | 436.33K | Avg Vol | 1.73M | EPS | -2.14 | P/E | N/A | Forward P/E | -9.31 |
| Beta | 7.68 | Short Ratio | 0.66 | Inst. Own | 13.72% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-14 | 50-d Avg | 0.66 | 200-d Avg | 1.73 | 1yr Est | 6.30 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2024-11-14 | 2024-09 | -0.7 | -0.4 | 0.3 | 42.86% |
| 2024-08-14 | 2024-06 | 0 | -0.6 | N/A | N/A |
| 2024-08-14 | 2024-06 | 0 | N/A | N/A | N/A |
| 2024-05-14 | 2024-03 | 0 | -1.63 | N/A | N/A |
| 2024-05-14 | 2024-03 | 0 | N/A | N/A | N/A |
| 2024-03-28 | 2023-12 | 0 | -3.05 | N/A | N/A |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2024-11-20 | Ascendiant Capital | Upgrade | Buy | Buy |
| 2024-11-19 | Alliance Global Partners | Upgrade | Buy | Buy |
| 2024-08-20 | Ascendiant Capital | Upgrade | Buy | Buy |
Profile
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2023-06-19 | HUNTSMAN RONALD KIRK | Chief Executive Officer | 1.83M | Purchase |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Strategic Wealth Investment Group, LLC | 100.00K | 512.00K | 2.07% |
| 2024-09-29 | Geode Capital Management, LLC | 28.80K | 147.47K | 0.60% |
| 2024-09-29 | OMERS Administration Corporation | 25.00K | 128.00K | 0.52% |
| 2024-09-29 | Commonwealth Equity Services, LLC | 21.00K | 107.52K | 0.43% |
| 2024-09-29 | Sabby Management, LLC | 20.50K | 104.97K | 0.42% |
| 2024-09-29 | Two Sigma Investments, LP | 20.48K | 104.87K | 0.42% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-10-30 | Fidelity Extended Market Index Fund | 18.25K | 93.42K | 0.38% |
| 2024-09-29 | Vanguard Extended Market Index Fund | 10.58K | 54.16K | 0.22% |
| 2024-10-30 | Fidelity Total Market Index Fund | 5.83K | 29.82K | 0.12% |
| 2024-10-30 | Fidelity Series Total Market Index Fund | 5.67K | 29.02K | 0.12% |
Split
| Split | Date |
|---|---|
| 1 : 25 | 2023-10-27 |